Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 7, 2013-09 ,pp. : 971-978

Bentham Science Publishers

Access to resources Recommend Favorite

?-lactam Structured, 4-(4-(Methylsulfonyl)phenyl)-1-pentyl-3-phenoxyazetidin-2-one: Selectively Targets Cancerous B Lymphocyte Mitochondria

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 9, 2017-09 ,pp. : 1292-1301

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells

By  

International Journal of Oncology, Vol. 46, Iss. 3, 2015-01 ,pp. : 1405-1411

Spandidos Publications

Access to resources Recommend Favorite

EtBr-induced selective degradation of mitochondria occurs via autophagy

By            

Oncology Reports, Vol. 30, Iss. 3, 2013-01 ,pp. : 1201-1208

Spandidos Publications

Access to resources Recommend Favorite

Selective targeting of homologous DNA recombination repair by gemcitabine

By Wachters F.M.   van Putten J.W.G.   Maring J.G.   Zdzienicka M.Z.   Groen H.J.M.   Kampinga H.H.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 2, 2003-10 ,pp. : 553-562

Elsevier

Access to resources Recommend Favorite